Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Modified factor VII described for coagulation-related disorders

June 21, 1996

A02131-1: Novel PDE V inhibitor

June 14, 1996

Corvas reveals anticoagulant proteins

June 14, 1996

Thrombin/trypsin inhibitors from Oscillatoria agardhii

June 14, 1996

FDA allows initiation of clinical trials on Autologous Fibrinogen Delivery (AFD) kit

June 7, 1996

Genetics Institute readies factor IX marketing application

June 7, 1996

Cor Therapeutics' NDA for Integrilin faces FDA review

June 7, 1996

Gea claims antiplatelet and fibrinolytic compounds

June 7, 1996

PharmaGenics discloses oligonucleotides

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...